2022
DOI: 10.1007/978-981-19-4957-9_1
|View full text |Cite
|
Sign up to set email alerts
|

Point-of-Care Testing of COVID-19: Current Status, Clinical Impact, and Future Therapeutic Perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 211 publications
0
3
0
Order By: Relevance
“…Since it is likely that multiple countries will have to go through this scenario again, alternative testing set-ups have been considered. In order to lighten the socioeconomic and organizational burden of the healthcare system and patients, implementing PCR testing in general practices could be a potentially successful alternative in future pandemic situations, as well as an overall improvement of diagnostics (2).…”
Section: Trial Registration N/amentioning
confidence: 99%
See 1 more Smart Citation
“…Since it is likely that multiple countries will have to go through this scenario again, alternative testing set-ups have been considered. In order to lighten the socioeconomic and organizational burden of the healthcare system and patients, implementing PCR testing in general practices could be a potentially successful alternative in future pandemic situations, as well as an overall improvement of diagnostics (2).…”
Section: Trial Registration N/amentioning
confidence: 99%
“…strep A antigen and C-Reactive Protein (CRP) testing has been the traditional standard procedure for examining patients with acute respiratory tract infections (RTI) in primary care. Recently, there has been an increasing interest in adding Point-of-care PCR testing for infectious diseases as a standard procedure, since it may not only save time spent for each patient compared to usual PCR testing with specimens sent to a laboratory, but also offer the possibility of diagnosing other infectious agents than current POC tests (2). Cobas® Liat® is a PCR tester developed for rapid testing in case of upper Implementing new technology in health care organizations can be challenging, and studying how new technology is imbedded in clinical practice and how professionals experience the potential added value is important to policymaking.…”
Section: Trial Registration N/amentioning
confidence: 99%
“…These studies illustrated that technology design, stakeholder engagement, and sufficient evidence on utility aid adoption. In addition, the COVID-19 pandemic has triggered public recognition and investment in POCTs ( 15 , 16 ) which may influence adoption of other tests. This study examines European stakeholders’ views and experiences of implementing novel POCTs in primary care, and their views on the impact of the COVID-19 pandemic in this area.…”
Section: Introductionmentioning
confidence: 99%